Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Broncho-Vaxom in Children with Atopic Dermatitis
NCT03047954Phase 3Completed
- Sponsor
- CSL Vifor
- Start
- Jul 2003
- Primary completion
- Dec 2006
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of OM-85 in atopic dermatitis (AD), sponsored by CSL Vifor. Started Jul 2003; status: completed.
02
Drugs
OM-85
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03047954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03047954.